Pharmaceuticals Ultrasector Financials
| PHPIX Fund | USD 27.85 0.48 1.75% |
Pharmaceuticals |
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Pharmaceuticals Ultrasector Fund Summary
Pharmaceuticals Ultrasector competes with Goehring Rozencwajg, Franklin Natural, World Energy, Salient Mlp, and Oil Gas. The fund invests in financial instruments that the fund Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the pharmaceuticals segment of the SP Total Market Index, which comprises the following sub-industry pharmaceuticals. The fund is non-diversified.Specialization | Trading--Leveraged Equity, Large |
| Instrument | USA Mutual Fund View All |
| Exchange | NMFQS Exchange |
| Business Address | Profunds |
| Mutual Fund Family | ProFunds |
| Mutual Fund Category | Trading--Leveraged Equity |
| Benchmark | Dow Jones Industrial |
| Phone | 888 776 3637 |
| Currency | USD - US Dollar |
Pharmaceuticals Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pharmaceuticals Ultrasector's current stock value. Our valuation model uses many indicators to compare Pharmaceuticals Ultrasector value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pharmaceuticals Ultrasector competition to find correlations between indicators driving Pharmaceuticals Ultrasector's intrinsic value. More Info.Pharmaceuticals Ultrasector Profund is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about 0.40 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Pharmaceuticals Ultrasector Profund is roughly 2.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pharmaceuticals Ultrasector's earnings, one of the primary drivers of an investment's value.Pharmaceuticals Ultrasector Systematic Risk
Pharmaceuticals Ultrasector's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pharmaceuticals Ultrasector volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Pharmaceuticals Ultrasector correlated with the market. If Beta is less than 0 Pharmaceuticals Ultrasector generally moves in the opposite direction as compared to the market. If Pharmaceuticals Ultrasector Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pharmaceuticals Ultrasector is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pharmaceuticals Ultrasector is generally in the same direction as the market. If Beta > 1 Pharmaceuticals Ultrasector moves generally in the same direction as, but more than the movement of the benchmark.
Pharmaceuticals Ultrasector December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pharmaceuticals Ultrasector help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pharmaceuticals Ultrasector Profund. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pharmaceuticals Ultrasector Profund based on widely used predictive technical indicators. In general, we focus on analyzing Pharmaceuticals Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pharmaceuticals Ultrasector's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.71 | |||
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 7.33 | |||
| Value At Risk | (2.48) | |||
| Potential Upside | 2.61 |
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |